22-07-26 Teligent, Inc. Went Out of Business CI
22-07-15 Second Amended Liquidation Plan Approved for Teligent, Inc. CI
22-05-25 Second Motion for Exclusivity Period Extension Approved For Teligent, Inc. CI
22-05-24 Second Amended Joint Liquidation Plan Filed by Teligent, Inc. CI
22-04-29 First Amended Disclosure Statement Approved for Teligent, Inc. CI
22-04-27 First Amended Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc. CI
22-04-08 Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc. CI
22-02-28 First Motion for Exclusivity Period Extension Approved For Teligent, Inc. CI
22-02-22 Motion for Case Conversion Filed by Teligent, Inc. CI
22-02-09 First Motion for Exclusivity Period Extension Filed by Teligent, Inc. CI
22-02-02 Pharmaceutical Associates, Inc. completed the acquisition of Generic and Branded US Marketing Authorizations of Teligent, Inc. (OTCPK:TLGT.Q). CI
22-02-02 Hikma Pharmaceuticals PLC completed the acquisition of Canadian assets of Teligent Inc from Teligent, Inc. (OTCPK:TLGT.Q). CI
22-01-19 Motion for Asset Sale Approved for Teligent, Inc. CI
22-01-19 Motion for Asset Sale Approved for Teligent, Inc. CI
22-01-18 Motion for Asset Sale Approved for Teligent, Inc. CI
22-01-16 Asset Purchase Agreement Filed by Teligent, Inc. CI
22-01-16 Asset Purchase Agreement Filed by Teligent, Inc. CI
22-01-16 Asset Purchase Agreement Filed by Teligent, Inc. CI
22-01-16 Hikma Pharmaceuticals PLC agreed to acquire Canadian assets of Teligent Inc. from Teligent, Inc. (OTCPK:TLGT.Q) for $45.7 million. CI
22-01-14 Notice of Selection of Successful Filed for Teligent, Inc. CI
22-01-13 Notice of Selection of Successful Filed for Teligent, Inc. CI
22-01-13 Notice of Selection of Successful Filed for Teligent, Inc. CI
21-12-14 Bidding Procedure Approved for Teligent, Inc. CI
21-11-28 Motion for Asset Sale Approved for Teligent, Inc. CI
21-11-24 Motion for Asset Sale Filed by Teligent, Inc. CI
No results match your criteria